|
Aug 7
|
Why NeoGenomics (NEO) Stock Is Trading Up Today
|
|
Aug 1
|
Earnings Release: Here's Why Analysts Cut Their NeoGenomics, Inc. (NASDAQ:NEO) Price Target To US$8.72
|
|
Jul 30
|
Down 29.2% in 4 Weeks, Here's Why NeoGenomics (NEO) Looks Ripe for a Turnaround
|
|
Jul 30
|
Peloton upgraded, Booking downgraded: Wall Street's top analyst calls
|
|
Jul 30
|
NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
|
|
Jul 30
|
NeoGenomics Second Quarter 2025 Earnings: EPS Misses Expectations
|
|
Jul 30
|
Fort Myers-based NeoGenomics sees stock plunge after reporting mixed results for Q2
|
|
Jul 29
|
Why NeoGenomics (NEO) Shares Are Falling Today
|
|
Jul 29
|
Why Myriad Genetics (MYGN) Shares Are Falling Today
|
|
Jul 29
|
NeoGenomics (NEO) Meets Q2 Earnings Estimates
|
|
Jul 29
|
NeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8%
|
|
Jul 29
|
NeoGenomics Reports Second Quarter 2025 Results
|
|
Jul 28
|
NeoGenomics (NEO) Reports Q2: Everything You Need To Know Ahead Of Earnings
|
|
Jul 24
|
Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 18
|
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
|
|
Jul 2
|
Here’s Why NeoGenomics (NEO) Sold Off in Q1
|
|
Jul 1
|
NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
|
|
Jun 30
|
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
|
|
Jun 24
|
5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call
|
|
Jun 24
|
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
|